IREN
IREN Limited
There isn't enough reported data to score IREN yet.
ISBA
Isabella Bank Corporation
ISBA's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
ISBA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
ISBA's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like ISBA.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
ISBA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 8.1x | $23.34 | -41% |
| Forward | 11x | $39.60 | — |
| Fair | 12x | $35.44 | -11% |
| Current | 14x | $39.60 | — |
| Expensive | 16x | $44.67 | +13% |
Historical ranges are pointers, not guarantees.
ISBA's PE is in its fair range at 14x. If earnings grow as analysts expect, today's price would be 11x next year's earnings.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
ISBA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for ISBA, but weaker profitability.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
ISBA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.65 | +27% |
| Q3 2026 | $2.87 | +17% |
| Q2 2026 | $2.72 | +24% |
| Q1 2026 | $2.71 | +38% |
| Q4 2025 | $2.56 | +38% |
| Q3 2025 | $2.46 | +34% |
| Q2 2025 | $2.19 | +11% |
| Q1 2025 | $1.97 | -7.1% |
| Q4 2024 | $1.86 | -22% |
ISBA has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
ISBA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.9M | +17% |
| Q2 2026 | $22.5M | +19% |
| Q1 2026 | $21.2M | +18% |
| Q4 2025 | $21.2M | +14% |
| Q3 2025 | $20.5M | +14% |
| Q2 2025 | $18.8M | +9.7% |
| Q1 2025 | $18.1M | +8% |
| Q4 2024 | $18.5M | +8.2% |
ISBA's revenue has grown year over year for nine quarters in a row: $24M last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | +3.8 points |
| Q2 2026 | 28% | -5.3 points |
| Q1 2026 | 28% | +1.2 points |
| Q4 2025 | 32% | +6.2 points |
| Q3 2025 | 31% | +9.3 points |
| Q2 2025 | 33% | +8.9 points |
| Q1 2025 | 27% | +5.1 points |
| Q4 2024 | 26% | -0.4 points |
ISBA has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
ISBA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.9M | +181% |
| Q2 2026 | $7.3M | +0.8% |
| Q1 2026 | $3.2M | -13% |
| Q4 2025 | $10.6M | +61% |
| Q3 2025 | $1.7M | -49% |
| Q2 2025 | $7.2M | +44% |
| Q1 2025 | $3.7M | +47% |
| Q4 2024 | $6.6M | +62% |
ISBA has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
ISBA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.2% | +306K shares |
| 1 year | +3.7% | +271K shares |
| 3 years | +1% | +72.5K shares |
| 5 years | -5% | -402K shares |
| Available history | -5.6% | -452K shares |
ISBA has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $136,000 |
| Q2 2026 | $224,000 |
| Q1 2026 | $402,000 |
| Q4 2025 | $1.5M |
| Q3 2025 | $609,000 |
| Q2 2025 | $1.5M |
| Q1 2025 | $1.1M |
| Q3 2024 | $1M |
ISBA spent $2M buying back its own shares over the past year.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
ISBA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -3.7x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.8x | Net Cash |
| Q4 2025 | 0.1x | Very low |
| Q3 2025 | -5.4x | Net Cash |
| Q2 2025 | -3.6x | Net Cash |
| Q1 2025 | -2.0x | Net Cash |
| Q4 2024 | 0.3x | Very low |
ISBA has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like ISBA.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
ISBA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.7 | Neutral |
| Stochastic | 61.5 | Neutral |
ISBA's weekly RSI is 49 (neutral) and its Stochastic is 61 (neutral).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
ISBA PE vs Financial Services Sector
| Metric | ISBA | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 6% above |
| PE % | 62 | 63 | 1 pt below |
ISBA is trading at 14x earnings, in line with the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
ISBA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.6 | 2.5% above |
| 20 week MA | $39.2 | 1.1% above |
| 50 week MA | $43.4 | 8.8% below |
| 100 week MA | $36.8 | 7.7% above |
| 200 week MA | $28.9 | 37% above |
ISBA has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
ISBA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $24.2 | $19.8 | -18% |
| 2021 | $19.8 | $26.3 | +33% |
| 2022 | $26.3 | $23.0 | -13% |
| 2023 | $23.0 | $21.5 | -6.5% |
| 2024 | $21.5 | $26.0 | +21% |
| 2025 | $26.0 | $51.6 | +99% |
| 2026 YTD | $51.6 | $39.6 | -23% |
ISBA has the edge over IREN on returns for 2026, with the stronger performance.